Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Mar 1, 2026
10w| Drug Name | Phase |
|---|---|
Placebo oral tablet | Phase 3 |
Tazemetostat | Phase 2 |
Prednisolone | Phase 2 |
2 upcoming, 0 past
Primary completion for Placebo oral tablet trial (NCT04224493) in Relapsed/Refractory Follicular Lymphoma
SourcePrimary completion for Tazemetostat trial (NCT04224493) in Relapsed/Refractory Follicular Lymphoma
Source